Speech-Language Pathologists in Russell Springs, KY Accepting Medicare
5 Speech-Language Pathologists found. Showing 1 - 5
 Sara Redmon Poynter, MS CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 250 S Highway 76, Russell Springs, KY 42642 Phone: 270-585-2455 |
Ms. Carol Annette Southard, M.S. CCC/SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 1841 Old Clear Springs Rd, Russell Springs, KY 42642 Phone: 606-305-1355 |
Lacey Pritchard, M.S, CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 762 John Streat Rd, Russell Springs, KY 42642 Phone: 270-566-3323 Fax: 270-343-6059 |
Dr. Jenny M Burton, PH.D., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 53 Farley Rd, Russell Springs, KY 42642 Phone: 513-319-7889 |
Shaina Renee Eubank, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 232 Lakewood Dr, Russell Springs, KY 42642 Phone: 270-566-1158 |
News Archive
Nanion's automated patch clamp platforms show unparalleled results using stem cell derived cardiomyocytes
The Patchliner and the SyncroPatch 96 have successfully been used for compound analysis under current- and voltage clamp recording conditions using different stem cell-derived cardiomyocytes. The exceptional cell-platform-compatibility and the unique experimental possibilities offered by Nanion's platforms open up whole new avenues for compound safety testing.
Watson, Natco confirm development agreement for generic Revlimid
Watson Pharmaceuticals, Inc. and Natco Pharma Limited today confirmed an exclusive, U.S. development and license agreement, to develop and commercialize lenalidomide 5, 10, 15 and 25 mg tablets. The companies also confirmed that Natco has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market its lenalidomide 5, 10, 15 and 25 mg product. Natco's lenalidomide tablets are generic versions of Celgene's Revlimid ® Tablets.
New study highlights survey vulnerabilities
Some 8.3 percent of California teens smoke cigarettes. No, wait, make that 4.5 percent. Or is it really 14.2 percent?
US markets for neurosurgical and neurovascular devices to grow to $240 million by 2016
According to Millennium Research Group, the global authority on medical technology market intelligence, the market for the specialized devices used for neurosurgical and neurovascular treatments will grow to $240 million by 2016, driven largely by an aging population in the United States that will suffer an increasing incidence of conditions such as stroke, cerebral aneurysms and intracranial atherosclerosis disease.
Maternal deaths drop by nearly half worldwide over 20 years; Greater progress still needed, U.N. reports
"The number of women dying of pregnancy- and childbirth-related complications has almost halved in 20 years, according to new estimates released [on Wednesday] by the United Nations, which stressed that greater progress is still needed in significantly reducing maternal deaths," the U.N. News Centre reports.
› Verified 4 days ago
Chiropractors
Speech-Language Pathologists
Optometrists
Podiatrists
Physical Therapists